Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed. It focuses on Schizophrenia.
Location not clearly listedThis study is completed in Spain. It is testing atomoxetine for ADHD.
Multiple locations, including BadajozThis study was terminated in the United States and in Canada. It is testing AVE1625 for schizophrenia.
Multiple locations, including BridgewaterThis study is completed in France. 4979 for Addiction.
In Villejuif
This study is completed in Argentina, in Brazil, in Germany, .... It is testing celecoxib for schizophrenia.
Multiple locations, including La PlataThis study is completed in the United States, in the United Kingdom, and in Ireland. It is testing COMP360 Psilocybin Therapy for Eating disorders.
Multiple locations, including San DiegoThis study is completed in the United States. It is testing Dex-Methylphenidate Extended Release 30 mg Versus 20 mg for ADHD.
Multiple locations, including Little RockThis study is completed in the United States, in Bulgaria, in Croatia, .... It is testing elpipodect for schizophrenia.
Multiple locations, including BentonvilleThis study is active but not recruiting in the United States. It is testing endoxifen for Bipolarity.
Multiple locations, including CerritosThis study was terminated. It is testing Eslicarbazepine Acetate (BIA 2-093) for manic episodes in bipolarity type I.
Location not clearly listedThis study is completed. It is testing Eslicarbazepine Acetate (BIA 2-093) for manic episodes in bipolarity type I.
Location not clearly listedThis study is completed in Spain. It is testing ESLICARBAZEPINE ACETATE (BIA 2-093) for manic episodes in bipolarity type I.
In SpainHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.